Zydus Lifesciences’ US division recalls 3,144 bottles of chlorproMAZINE Hydrochloride Tablets

14 Apr 2025 Evaluate

Zydus Lifesciences’ US generics division -- Zydus Pharmaceuticals (USA) Inc is recalling 3,144 bottles of chlorproMAZINE Hydrochloride Tablets, USP 10 mg, a medication used to treat mental health conditions, like schizophrenia and bipolar disorder. The drug firm is recalling the affected lot due to CGMP deviations. There was ‘presence of N-Nitroso-Desmethyl Chlorpromazine impurity above the recommended interim limit’. The company initiated the Class II recall on April 3, 2025.

Zydus Lifesciences (formerly known as Cadila Healthcare), a company limited by shares, incorporated and domiciled in India, operates as an integrated pharmaceutical company with business encompassing the entire value chain in the research, development, production, marketing and distribution of pharmaceutical products.

Zydus Lifesciences Share Price

922.45 -1.25 (-0.14%)
11-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1806.90
Dr. Reddys Lab 1272.95
Cipla 1512.10
Zydus Lifesciences 922.45
Lupin 2080.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×